We investigated the potential role of the co-substrate, thiocyanate (SCN ؊ ), in modulating the catalytic activity of myeloperoxidase (MPO) and other members of the mammalian peroxidase superfamily (lactoperoxidase (LPO) and eosinophil peroxidase (EPO) ؊ concentration, depending on the experimental conditions. Collectively, these results illustrate for the first time the potential mechanistic differences of these three enzymes. A modified kinetic model, which incorporates our current findings with the mammalian peroxidases classic cycle, is presented.
Myeloperoxidase (MPO) 1 and other members of the mammalian peroxidase superfamily (eosinophil peroxidase (EPO) and lactoperoxidase (LPO)) display a crucial difference (within a wide range of biological processes) in their unique ability in catalyzing the H 2 O 2 -dependent peroxidation of halides and pseudohalides to produce antimicrobial agents and hypohalous acids (1) (2) (3) (4) (5) (6) (7) . These heme-containing enzymes share 50 -70% overall amino acid sequence homology but differ from each other with respect to their sites of expression, primary sequences, and substrate specificities (1, 2, 8 -10) . MPO is a 150 -165-kDa molecule synthesized during myeloid differentiation that constitutes the major component of the neutrophil azurophilic granules (11, 12) . The enzyme is a homodimer comprising of a pair of light and heavy chains derived from a single gene product (12, 13) with its subunits joined by a single disulfide bridge (12). The heavy chain contains an iron bound by a novel protoporphyrin IX derivative, which is covalently linked to the heavy chain polypeptide (14 -16) . EPO is a monomeric molecule comprised of a light chain and a heavy chain with molecular masses of 15.5 and 50 kDa, respectively (17) . This enzyme is stored in eosinophil granules and catalyzes the formation of antimicrobial species from the oxidation of Br 
and SCN
Ϫ (17) (18) (19) . LPO is a monomeric single polypeptide chain with a molecular mass of 78.5 kDa (20 -23) . LPO has been identified as an antimicrobial agent within exocrine gland secretions such as milk, saliva, and tears through the oxidation of thiocyanate by H 2 O 2 to yield the intermediary oxidation product hypothiocyanite (OSCN Ϫ ) (24, 25) . The properties of the heme in MPO, EPO, and LPO have been characterized by a wide variety of spectroscopic techniques, including optical absorption, stopped-flow, electron paramagnetic resonance, and resonance Raman spectroscopy (26 -37) . These techniques, with a combination of structure analysis (16, 38 -39) and advanced computer modeling (40) , have shown that the heme pockets of the mammalian peroxidases are envisioned to form the catalytic site where the stepwise reduction of H 2 O 2 takes place. The simplified mechanism that governs the catalytic activity of mammalian peroxidase superfamily can be represented by the classic peroxidases catalytic cycle. In this cycle, represented here by Equations 1-4, (33, 41) . Compound I is capable of oxidizing either halides and pseudohalides through a 2e Ϫ transition, generating the ground state and the corresponding hypohalous acid (Equation 2) or oxidizing multiple organic and inorganic molecules (AH 2 ) by two successive sequential 1e Ϫ transitions generating their corresponding cation ( ⅐ AH) and the peroxidase intermediates Compound II (E-Fe(IV)ϭO) and E-Fe(III), re-spectively (Equations 3 and 4) (33, (41) (42) (43) . Compound II is a longer lived intermediate whose decay to ground state is considered to be the rate-limiting step during steady-state catalysis (33, 44) . Acceleration in Compound II formation and decay has been noted with a series of organic and inorganic substrates (28, 30, 33, (41) (42) (43) and physiological reductants like nitric oxide (NO) and superoxide (O 2 . ) (28, 30, 33, (41) (42) (43) .
Thiocyanate binds close enough to the heme iron of peroxidase to influence both its reduction potential and binding affinity to small molecules, such as NO and CO, when these molecules bind to the enzyme's heme center (16, 28 -30, 38, 39) . Recent x-ray crystal structure analysis and a variety of spectroscopic measurements have shown that SCN Ϫ binding occurs at distal heme cavity and serves as either a substrate or inhibitor, causing a diverse impact on the catalytic characteristic behavior of mammalian peroxidases and function (16, 28 -30, 38, 39) . In some cases, these co-substrates bind to the peroxidase heme iron and form the corresponding low spin, sixcoordinate complex that inhibits the catalytic activity of the enzyme (45) .
Despite the potential significance of mammalian peroxidases to both human health and disease, little is known about the factors that govern their substrate selectivity and specificity. Previous kinetic studies with mammalian peroxidases have been limited in scope by focusing primarily on the direct reaction of SCN Ϫ with Compound I (36, 37, 44, 46, 47) . In the present studies, we utilize a combination of optical absorbance, rapid kinetic measurements, and NO binding studies to assess the distinct conformational changes that occur upon SCN Ϫ binding and its influence on the catalytic activity of MPO and other members of the mammalian peroxidase superfamily. Our results indicate that SCN Ϫ binding regulates the catalytic activity of MPO, EPO, and LPO, which appears to result from significant electronic and/or conformational alterations in the catalytic sites of these three enzymes that are caused by SCN Ϫ .
EXPERIMENTAL PROCEDURES
Materials-NO gas was purchased from Matheson Gas Products, Inc. and used without further purification. For each experiment, a fresh saturated stock of NO was prepared under anaerobic conditions. The extent of nitrite/nitrate (NO 2 Ϫ /NO 3 Ϫ ) build-up in NO preparations over the time course used for the present studies was Ͻ1-1.5% (per mole of NO), as determined by anion exchange high performance liquid chromatography under anaerobic conditions (48) . All other reagents and materials were of the highest purity grades available and obtained from Sigma or the indicated source.
Enzyme Purification-MPO was purified from detergent extracts of human leukocytes as described (49) . Trace levels of contaminating eosinophil peroxidase were then removed by passage over a sulfopropylSephadex column (50) . The purity of isolated MPO was established by demonstrating a Reinheitszahl (RZ) value of Ͼ0.85 (A 430 /A 280 ) by means of SDS-PAGE analysis with Coomassie Blue staining and in-gel tetramethylbenzidine peroxidase staining to confirm no observable contaminating eosinophil peroxidase activity (51) . EPO was purified from porcine whole blood as described previously (52) . The purity of EPO was confirmed by demonstrating an RZ of Ͼ0.9 (A 415 /A 280 ) via SDS-PAGE analysis with Coomassie Blue staining and in-gel tetramethylbenzidine peroxidase staining (53 ) functions as indicated. Signal-to-noise ratios for all kinetic analyses were improved by averaging at least 6 -8 individual traces. In some experiments the stopped-flow instrument was attached to a rapid scanning diode array device (Hi-Tech) designed to collect a multiple number of complete spectra (200 -800 nm) at specific time ranges. The detector was automatically calibrated relative to a holmium oxide filter, as it has spectral peaks at 360.8, 418.5, 446.0, 453.4, 460.4, 536.4, and 637.5 nm, which were used by the software to correctly align pixel positions with wavelength. Rapid scanning stopped-flow experiments involved mixing solutions of MPO (3 M) with buffer solutions containing 40 M H 2 O 2 in the absence and presence of increasing SCN Ϫ concentrations at 10°C. Spectroscopy-Optical spectra were recorded on a Cary 100 Bio UVvisible spectrophotometer at 25°C. Anaerobic spectra were recorded using septum-sealed quartz cuvettes that could be attached through a quick-fit joint to an all-glass vacuum system. MPO samples were made anaerobic by several cycles of evacuation and equilibrated with catalyst-deoxygenated N 2 . Separate buffer solutions were evacuated, gassed with N 2 , and anaerobically transferred either to the stopped-flow instrument or to anaerobic cuvettes using gas-tight syringes. Cuvettes were maintained under N 2 or NO positive pressure during spectral measurements.
Solution Preparation-A fresh saturated stock of NO was prepared under anaerobic conditions. Anaerobic 0.2 M sodium phosphate buffer solutions, pH 7.0, containing various concentrations of NO were prepared by mixing different volumes of buffer saturated with NO gas at 21°C with an anaerobic buffer solution. A saturating concentration of NO at 21°C is ϳ2 mM. 
RESULTS

Effects of SCN Ϫ on NO Binding to MPO Heme Iron-To assess the influence of SCN
Ϫ on the catalytic activity of MPO, the rates of NO binding to the Fe(III) form of MPO have been determined in the presence of increasing SCN Ϫ concentrations. Investigations were carried out under two different circumstances, either a fixed amount of NO and varying concentrations of SCN Ϫ or a fixed amount of SCN Ϫ and varying levels of NO. As shown in Fig. 1 , the plots of the apparent rate constants for NO binding as a function of NO concentration were linear, consistent with a simple one-step mechanism. As shown in Equation 5 ,
the positive intercepts confirm that NO binds to MPO-Fe(III) by a reversible process. These kinetic parameters suggest that SCN Ϫ modulates the affinity of MPO-Fe(III) toward NO. The second-order combination rate constants (k on ) calculated from the slopes were plotted as a function of SCN Ϫ concentration and showed a bell-shaped relationship (Fig. 2) , with a minimum centered at biologically relevant levels of SCN Ϫ (60 M). Collectively, these results indicate that SCN Ϫ binds within the enzyme system and modulates the affinity of MPO-Fe(III) toward NO.
Formation of MPO, EPO, and LPO Compound II during the Metabolism of SCN
Ϫ -We next utilized diode array spectrophotometry to study the effect of SCN Ϫ on MPO, EPO, and LPO intermediate formation, duration, and decay, as these events occur during steady-state catalysis. Ϫ ranging from 20 -160 M. The time courses for the formation, duration, and decay of MPO steady-state catalysis were examined by following the absorbance changes at 434 and 455 nm. As shown in Fig. 5 , we observed a rapid increase in absorbance at 455 nm followed by a steady state in which the intermediate formation remained relatively constant, with a final decay to the origin after MPO had oxidized all of the available substrate, H 2 O 2 . The decay of the steady-state reaction is biphasic. There is a rapid initial decrease in absorbance (Fig. 5) followed by a much slower decrease in absorbance over the next 500 s (data is not included in Fig. 5 ). As summarized in Fig. 6 , the addition of SCN Ϫ to the MPO reaction results in dramatic effects on the duration and decay of the steady-state accumulation rate. The rate of steady-state accumulation was decreased in the presence of SCN Ϫ in a concentration-dependent and saturable manner (Fig. 6A) . The rate of its initial decay increased in a linear manner as a function of SCN Ϫ concentration (Fig. 6B) , yielding a second-order combination rate constant (k on ) of 1 ϫ 10 4 M Ϫ1 s Ϫ1 calculated from the slope. In addition, SCN Ϫ influences the level of the steady-state accumulation and stability as reflected by the amplitude and duration of the stopped-flow traces, respectively. As the concentration of SCN Ϫ present in the reaction mixture increased, both the steady-state level and the amount of the intermediates generated progressively decreased (Fig. 6C) . When the reactions were monitored at 434 nm the direction of absorbance change was reversed, and the signal amplitudes enhanced but otherwise proceeded with identical kinetics (data not shown). Collectively, the spectra of the intermediates initially formed following initiation of the reaction indicate that the majority of MPO exists as a Compound II and that its formation occurs without the accumulation of Compound I. Similar results were obtained for EPO (data not shown), indicating that both MPO and EPO display a similar kinetic mechanism in metabolizing SCN Ϫ .
Effect of SCN
Ϫ on the Formation, Duration, and Decay of LPO Steady-state Catalysis-The time courses for the formation, duration, and decay of LPO steady-state catalysis were examined by following the decrease in absorbance changes at 412 nm. At each SCN Ϫ concentration tested, there is a rapid decrease in absorbance followed by a steady state in which the intermediate formation remained relatively constant and finally decayed exponentially to the origin after LPO had oxidized all of the available substrate, H 2 O 2 . However, it is apparent that as the SCN Ϫ concentration increased there was a decrease in rate of formation, a decrease in the duration of the steady state, and an increase in the decay rate (Fig. 7) . When the reactions were monitored at 434 nm the direction of absorbance change was reversed, and the signal amplitudes were reduced but otherwise proceeded with identical kinetics (data not shown). This behavior suggests that the spectral changes observed should reflect the change in LPO Compound II during catalysis. As summarized in Fig. 8 , the addition of SCN Ϫ to LPO reaction results in dramatic effects on the duration and decay of the steady-state accumulation rates. The rate of steady-state accumulation was decreased in the presence of SCN Ϫ in a concentration-dependent and saturable manner (Fig. 8A) . The rate of its decay increased in a linear manner as a function of SCN Ϫ concentration (Fig. 8B) , yielding a secondorder combination rate constant (k on ) of 7 ϫ 10 bility as reflected by amplitude and duration of the stoppedflow traces, respectively. As the concentration of SCN Ϫ present in the reaction mixture was increased, both the steady-state level and the amount of the intermediates generated progressively decreased (Fig. 8C) (Fig. 9, top) . The first step occurs immediately after the enzyme addition and is attributable to the formation of MPO Compound I. The second step is much slower and is attributable to the reaction of MPO with H 2 O 2 after the conversion of MPO Compound II to ground state. When the same reaction was repeated by adding an MPO sample saturated with SCN Ϫ solution to a stirred H 2 O 2 solution, only the first step was observed (Fig. 9, bottom) . Similar results were obtained for both EPO and LPO. DISCUSSION 
Pre-incubation of SCN
Ϫ with MPO and other members of the mammalian peroxidase superfamily (e.g. EPO and LPO) causes multiple and sequential reactions and suggests a multi-functional role for SCN Ϫ before and during steady-state catalysis. Indeed, pre-incubation with SCN Ϫ prior to initiating peroxidation generates a more complex biological setting through its potential capacity to bind within the enzyme systems, above the heme prosthetic group, or directly to the heme iron, generating a six-coordinate low spin complex. SCN Ϫ binds within the MPO system, serves as a substrate or inhibitor, and modulates the heme iron microenvironment to cause a significant alteration in its catalytic site, thereby altering the enzyme's affinity toward H 2 O 2 . Rapid kinetic measurements utilizing sequential stopped-flow methods have indicated that the direct reaction between MPO, EPO, and LPO Compound I and SCN Ϫ is extremely fast and occurs with second-order rate constants ranging from 9.6 ϫ 10 7 to 2 ϫ 10 8 M Ϫ1 s Ϫ1 (33, 36, 37, 44, 46, 47) . Thus, the order of addition (the enzyme and H 2 O 2 mixed first and SCN Ϫ second, or the enzyme and SCN Ϫ mixed first and H 2 O 2 second) may have created a considerable degree of controversy, ambiguity, and diverse results in predicting the preferred biological substrate of the mammalian peroxidase superfamily.
Because MPO, EPO, and LPO Compound I formation rates are slower than the 2e Ϫ oxidation of SCN Ϫ , Compound I accumulation cannot be detected during steady-state catalysis (27, 33, 36, 37, 44, 46, 47) . Thus, the observed absorbance changes during SCN Ϫ metabolism should reflect the alteration in Compound II accumulation, duration, and decay. Rapid kinetic measurements indicated that MPO, EPO, and LPO Compound II is the predominant species formed, providing the first direct evidence for the involvement of Compound II in the catalytic inhibition of mammalian peroxidases. The kinetic parameters Ϫ concentration, LPO Compound II was also maintained at a constant level, whereas the enzyme continued to catalyze SCN Ϫ oxidation and HOSCN synthesis. We observed that increasing the SCN Ϫ concentration was accompanied by a modest decrease in the rate of Compound II formation, but with a significant decrease in accumulation, a decrease in duration, and a significant increase in the decay rate. LPO Compound II formation and the accompanying inhibition did not occur at a higher SCN Ϫ concentration. This behavior can be interpreted by either or both of the following statements. 1) The Compound II formation rate becomes slower than the complex decay; and 2) the majority of the reaction proceeds through a 2e Ϫ oxidation pathway. A general kinetic scheme of how SCN Ϫ interacts with mammalian peroxidase intermediates incorporated into the classic catalytic cycle is illustrated in Fig. 10 . This working kinetic model consists of two major pathways, namely the classical peroxidase cycle (pathway A) and the binding of a co-substrate to E-Fe(III), the formation of E( inh )-Fe(II) complex, and the effect of these bindings on the formation of Compound I (pathway B) (Fig. 10) . Compound I formation is rapid and occurs with a second-order rate constant ranging from 1 ϫ 10 7 to 4.3 ϫ 10 7 M Ϫ1 s Ϫ1 (27, 33, 36, 37, 44, 46, 47) . Mammalian peroxidase Compound I oxidizes halides and pseudohalides by a 2e Ϫ oxidation process yielding the corresponding hypohalous acid and the ground state (E-Fe(III)) (33, (41) (42) (43) . Alternatively, Compound I oxidizes organic and inorganic substrates by two sequential 1e Ϫ oxidations to ground state through the formation of Compound II, the rate-limiting step in the classic cycle of peroxidases (33, 44) .
NO, like CN Ϫ , binds to the MPO heme iron and displaces the water molecule (W1), which is hydrogen-bonded to the distal His-95 in the native enzyme. The bent mode of the Fe-N-O may allow a perturbation in the hydrogen bonding within the distal cavity. Formation of such a complex is accomplished with the movement of the iron atom into the porphyrin ring, generating its respective low spin, six-coordinate complex. SCN Ϫ is a relatively bulky molecule; its binding above the heme moiety of MPO may constrain NO binding by either filling the space directly above the heme or by promoting a protein conformational change that constricts the distal heme pocket (Fig. 11) . The ability of SCN Ϫ to modify the heme pocket of MPO and/or shield the catalytic site of the enzyme is directly reflected by the modulation of NO binding to the enzyme heme moiety. Varying the concentration of SCN Ϫ displays different types of impact on the MPO heme iron microenvironment. Indeed, the plot of the second-order combination rate constant (k on ) of NO binding to MPO-Fe(III) as a function of SCN Ϫ concentration displayed a bell-shaped curve with a negative slope over the range where SCN Ϫ concentrations were Ͻ60 M and a positive slope over the range where SCN Ϫ concentrations were Ͼ60 M, with saturation Ͼ300 M. This behavior may have a broader link effect on MPO activity, because the initial decrease in the second-order rate constant of NO combination (k on ) occurs within the range where SCN Ϫ binds to a distal cavity located in MPO Compound I and allows the direct contact with the oxyferryl oxygen. Under these circumstances, Compound I appears to act favorably in triggering electron transfer to the heme with subsequent conversion to hypothiocyanate as a final reaction product (16, 38, 39, 73) . This decrease was reversed and reaches saturation at higher SCN Ϫ concentrations, where SCN Ϫ binds to MPO at both the distal cavity and the proximal helix sites and forms an inactive complex (SCN-E-Fe(III) (inh) ). Indeed, Blair-Johnson et al. (73) have shown that the inhibitory complex with thiocyanate indicates replacement of chloride at the proximal helix halide binding site in addition to binding in the distal cavity in an orientation parallel with the heme (Fig.  11) . It was thought that halides binding at the distal cavity site inhibit the enzyme by interfering with the deprotonation of H 2 O 2 by the adjacent distal His-95 (16, 38, 39, 73) , a mechanism consistent with previous reports indicating that inhibition by halides is competitive with respect to H 2 O 2 (56 -59) . Thus, the saturation in a bell-shaped curve occurs, at a high concentration of SCN Ϫ (Ͼ300 M), when the two sites are occupied. Therefore, the plasma levels of SCN Ϫ (60 M) are crucial in saturating the substrate site of the enzyme, as judged by the inflection point in the bell-shaped curve that is illustrated in Fig. 2 . Consequently, the plasma level of SCN Ϫ may govern the catalytic reaction of MPO both in vivo and in vitro.
Identifying similarities and differences in the interactions between MPO and various members of the mammalian peroxidase superfamily yields valuable mechanistic insights into the role of Compound II formation in modulating catalytic activity and function. The Compound I of MPO, EPO, and LPO simultaneously catalyzes SCN Ϫ via 2e Ϫ and 1e Ϫ oxidation pathways, which leads to the formation of HOSCN and sulfur-centered thiocyanate radicals (SCN ⅐ ), respectively (60, 61 (Fig. 6C) . Thus, the plateau in the curve is governed by the rate of the 1e Ϫ oxidation reaction of SCN Ϫ by Compound I, which would then result from the cleavage of SCN Ϫ from the SCN-MPO( inh )-Fe(III) complex. Thus, the plot of the formation rate of Compound II plateaus at a rate that should be comparable with the rate of SCN-E (inh) -Fe(III) conversion to the active form, which, under these circumstances, is the formation of E-Fe(III) and/or SCN-E-Fe(III) (Fig. 10) . The low conversion rate constant limits E-Fe(III) bioavailability and subsequently attenuates the turnover number of peroxidation.
The time course for MPO Compound II decay monitored in the absence of SCN Ϫ , detected by monitoring the absorbance changes at 455 nm, is extremely slow and occurs with a rate constant of 0.008 s Ϫ1 at 10°C (28 -30 (36, 44, 47) . These results are consistent with the direct reaction between Compound I and SCN Ϫ , which, to a large extent, prevents the potential alteration in the heme pocket and, thereby, the formation of the inactive form of the enzyme that occurs upon the prior incubation of SCN Ϫ with the three enzymes. Binding of the co-substrate to the heme moiety generating the E-Fe(III)-SCN complex (Fig. 10 ) may considerably restrict H 2 O 2 access to the heme iron, and the slow rate of H 2 O 2 binding observed would then result from ligand replacement processes. There is no data available to support the notion that SCN Ϫ serves as a ligand in mammalian peroxidase when present at plasma levels. However, the presence of higher levels of SCN Ϫ (e.g. Ͼ1 mM) may promote the formation of such a complex (45) . Formation of E-Fe(III)-SCN can be characterized based on its distinctive absorbance feature, which displays a large red shift in the Soret absorbance region compared with native enzyme (45) . Whether the slow binding of H 2 O 2 to the enzyme occurs through conformational changes in the heme pocket geometry or because of the replacement reaction, the rate-limiting step becomes the binding of H 2 O 2 to the enzymes. Under all circumstances, the catalytic activity of the peroxidases will depend on multiple factors, including the concentration of SCN Ϫ versus H 2 O 2 , the affinity of the enzymes toward H 2 O 2 versus SCN Ϫ , and the rate of SCN-E-Fe(III) and E-Fe(III)-SCN breakdown (Fig. 10) . Changes in heme pocket geometry upon ligand binding have been described for cytochrome C peroxidase (70) , and the slower rates of NO binding to the Fe(III) forms of a number of heme proteins have been attributed to ligand replacement (69, 71, 72) . Ligation of SCN Ϫ to the distal heme would prevent access of H 2 O 2 to the catalytic site of the enzymes.
In summary, our current studies reveal for the first time that the formation of Compound II during steady-state catalysis is a fundamental feature of the kinetic reaction of mammalian peroxidases. Its formation during steady-state catalysis operates to down-regulate the catalytic activity of MPO, EPO, and LPO.
